3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Histologic Type
1
Neoplasms
1
Carcinoma
1
Adenocarcinoma
1
Interventions
tetulomab tetraxetan lu-177
2
osimertinib
2
fludarabine
2
entinostat
2
Pemetrexed
2
Lutetium
2
Carboplatin
2
spartalizumab
1
pembrolizumab
1
nirogacestat
1
interferon gamma-1b
1
gilteritinib
1
ficlatuzumab
1
emvododstat
1
denileukin diftitox
1
atezolizumab
1
Trabectedin
1
Taxes
1
Sunitinib
1
Radiosurgery
1
Oncolytic Virotherapy
1
Nivolumab
1
Lutetium-177
1
Interleukin-2
1
Interferon-gamma
1
Immunotherapy
1
Idarubicin
1
HuMax-IL8
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Granulocyte Colony-Stimulating Factor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Neoplasms by Histologic Type
×
Cobicistat
×
Clear all
NCT05494866
2025-03-25
IntenSify
German Cancer Research Center
Phase 1
Terminated
6 enrolled